Rumeyza Kazancioglu
Overview
Explore the profile of Rumeyza Kazancioglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
1184
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Madero M, Levin A, Ahmed S, Carrero J, Foster B, Francis A, et al.
Ann Intern Med
. 2025 Mar;
PMID: 40063957
Description: The Kidney Disease: Improving Global Outcomes (KDIGO) organization updated its existing clinical practice guideline in 2024 to provide guidance on the evaluation, management, and treatment of chronic kidney disease...
2.
Elcioglu O, Yatci B, Ozturk B, Mirioglu S, Gursu M, Kazancioglu R
BMC Nephrol
. 2025 Feb;
26(1):94.
PMID: 39994555
Background: Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a common hereditary disorder leading to end-stage kidney disease due to the progressive formation of renal cysts. Nephrolithiasis is a frequent complication...
3.
Islek T, Mirioglu S, Gursu M, Kazancioglu R, Demirel M, Selek S, et al.
Nefrologia (Engl Ed)
. 2024 Dec;
44(6):868-876.
PMID: 39701607
Background: There is still a lack of information regarding the impact of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on bone and mineral metabolism in patients with diabetes and chronic kidney disease...
4.
Toker K, Atas K, Mayadagli A, Gormezoglu Z, Tuncay I, Kazancioglu R
Healthcare (Basel)
. 2024 Nov;
12(21).
PMID: 39517373
Background: Patient no-show behavior is a critical factor complicating hospital resource optimization and causing waste. The inefficiency caused by patients' no-shows and the resulting increased operating costs negatively affect the...
5.
Martin D, Capron A, Fadhil R, Forsythe J, Padilla B, Perez-Blanco A, et al.
Transplantation
. 2024 Oct;
109(1):48-59.
PMID: 39437369
The avoidance of financial gain in the human body is an international ethical standard that underpins efforts to promote equity in donation and transplantation and to avoid the exploitation of...
6.
Martin D, Van Assche K, Cervantes L, Forsythe J, Muller T, Perez-Blanco A, et al.
Transplantation
. 2024 Oct;
109(1):60-72.
PMID: 39437368
Therapies derived from substances of human origin (SoHOs) such as organs, cells, and tissues provide life-saving or life-changing treatment for millions of people worldwide each year. However, many people lack...
7.
Martin D, Capron A, Fadhil R, Forsythe J, Padilla B, Perez-Blanco A, et al.
Transplantation
. 2024 Oct;
109(1):88-97.
PMID: 39437366
Trafficking in human organs, cells, and tissues has long been a source of concern for health authorities and professionals, and several international ethical guidance documents and national laws have affirmed...
8.
Sahutoglu T, Kazancioglu R, Ozkan M, Erkasap P, Ates K
Perit Dial Int
. 2024 Oct;
:8968608241287328.
PMID: 39360475
Introduction: Despite being an effective home-based kidney replacement therapy, peritoneal dialysis (PD) remains underutilized. The aim of the Renality-CASE training program was to assess its impact on nephrologists by expanding...
9.
Ali H, Begum Ozturk N, Herdan N, Luu H, Simsek C, Kazancioglu R, et al.
Hepatol Forum
. 2024 Oct;
5(4):207-210.
PMID: 39355834
Simultaneous liver-kidney transplantation (SLK) is a feasible option for patients with end-stage liver disease and concomitant renal dysfunction or end-stage renal disease. SLK has gained significant attention primarily due to...
10.
Sahutoglu T, Kazancioglu R
Kidney Int Rep
. 2024 Jul;
9(7):1945-1946.
PMID: 39081764
No abstract available.